James A. Retsema

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

James A. Retsema, Agnès Girard, W Schelkly et al. · Antimicrobial Agents and Chemotherapy · 1987 · 458 citations

Antimicrobial Chemotherapy, Drug Resistance, Macrolide Antibiotic Azithromycin +17

CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization

A. R. English, James A. Retsema, Arthur E. Girard et al. · Antimicrobial Agents and Chemotherapy · 1978 · 393 citations · Full text

<b>Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, <i>mefA</i>, from <i>Streptococcus pyogenes</i></b>

Joanna Clancy, J.W. Petitpas, Fadia B. Dib-Hajj et al. · Molecular Microbiology · 1996 · 360 citations

Novel Macrolide‐resistance Determinant, Bacteriology, Molecular Biology +17

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

Agnès Girard, D Girard, A. R. English et al. · Antimicrobial Agents and Chemotherapy · 1987 · 321 citations

Immunology, Pharmacotherapy, Antimicrobial Chemotherapy +18

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.

G. Michael Bright, A. Nagel, Jon Bordner et al. · The Journal of Antibiotics · 1988 · 237 citations · Full text